Matthew H Forsberg

42PUBLICATIONS
183CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 16, 2026
Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumours.

|May 18, 2026
CXCL13-CXCR5 Signaling in CD8+ T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell Carcinoma.

|Apr 17, 2026
PRMT5 inhibition sensitizes B-cell lymphoma cells to ferroptosis.

|Apr 03, 2026
Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumors.

Allison M Weisnicht, Fernanda Szewc, Monica Moonkyung Cho

|Jan 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

Liora Schultz, Kevin McNerney, Adam J Lamble

|Jan 09, 2026
Extracellular vesicles from mesenchymal stromal cells primed with synthetic toll-like receptor 4 agonists treat hematopoietic acute radiation syndrome.

John A Kink, Matthew H Forsberg, Derek M Krismer

Pageof 7

Frequent Collaborators

5 joint publications

Aicha Quamine

5 joint publications

Krishanu Saha

4 joint publications

Pippa F Cosper

4 joint publications

Melissa C Skala